| 000 | 01763 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518093144.0 | ||
| 264 | 0 | _c20200910 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.119.264499 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIida, Hiroyuki | |
| 245 | 0 | 0 |
_aPharmacokinetic-Pharmacodynamic-Efficacy Modeling of ONO-7579, a Novel Pan-Tropomyosin Receptor Kinase Inhibitor, in a Murine Xenograft Tumor Model. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _c06 2020 |
||
| 300 |
_a361-369 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeterografts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOrganic Chemicals _xpharmacokinetics |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aXenograft Model Antitumor Assays _xmethods |
| 700 | 1 | _aFujikawa, Ryu | |
| 700 | 1 | _aKozaki, Ryohei | |
| 700 | 1 | _aHarada, Ryuichi | |
| 700 | 1 | _aHosokawa, Yuya | |
| 700 | 1 | _aOgawara, Ken-Ichi | |
| 700 | 1 | _aOhno, Tomoya | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 373 _gno. 3 _gp. 361-369 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.119.264499 _zAvailable from publisher's website |
| 999 |
_c30785780 _d30785780 |
||